Pentacam corneal densitometry-guided treatment of adenoviral corneal subepithelial infiltrates: a comparative study between transepithelial phototherapeutic keratectomy and topical tacrolimus.
Aberration
Corneal densitometry
Epidemic keratoconjunctivitis
PTK
Subepithelial infiltrates
Tacrolimus
Journal
International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
12
05
2020
accepted:
16
08
2020
pubmed:
28
8
2020
medline:
22
6
2021
entrez:
28
8
2020
Statut:
ppublish
Résumé
To compare the changes in the measurement of corneal densitometry and total corneal higher-order aberrations (HOAs) between topical tacrolimus and transepithelial phototherapeutic keratectomy (Te-PTK) in the treatment of adenoviral corneal subepithelial infiltrates (SEIs). This is an interventional prospective randomized study, including 63 eyes of 35 patients with symptomatic adenoviral corneal SEIs for at least 6 months. All patients underwent previous topical steroid therapy associated with unsatisfactory response and/or complications. Patients were assigned into three groups: (1) Te-PTK group: Te-PTK with MMC 0.02% was performed by a Technolas; Teneo excimer laser; (2) tacrolimus group: tacrolimus 0.03% ointment was applied once daily for 2-6 months; the endpoint of treatment was based on the improvement in the corneal densitometry, BCVA, and OSDI; and (3) control group: no intervention was done. BCVA, corneal densitometry, and total corneal higher-order aberrations (HOAs) evaluation using Pentacam HR were done at the baseline, 1 week, and then 1, 3, 6, and 12 months of the study. The study population was similar between all groups. The mean follow-up was 12.75 ± 0.9 months. Bilateral corneal SEI was recorded at 80%. At 12-month follow-ups, the mean BCVA improved in both the Te-PTK and tacrolimus groups without significant changes in the control group. The mean corneal densitometry of the anterior, central, and total cornea decreased significantly in the Te-PTK and tacrolimus groups. HO-RMS and total RMS decreased significantly in the Te-PTK and tacrolimus groups. BCVA, corneal densitometry (anterior, central, and total cornea), and corneal aberrations (total coma, total trefoil, HO-RMS, and total RMS) values were significantly better for the Te-PTK and tacrolimus groups than the control group. There were no statistically significant differences between Te-PTK and tacrolimus groups in terms of BCVA, corneal densitometry, corneal HOA, and the persistence of corneal SEIs. The persistence of corneal SEIs was significantly lower in Te-PTK and tacrolimus groups than the control group. Te-PTK and topical tacrolimus are effective methods for the treatment of adenoviral corneal SEIs improving visual acuity, corneal densitometry, and corneal HOA. The densitometry program of the Pentacam may give an objective guide for the treatment of adenoviral corneal SEIs. ClinicalTrials.gov ID is NCT04267991.
Identifiants
pubmed: 32852646
doi: 10.1007/s10792-020-01553-8
pii: 10.1007/s10792-020-01553-8
doi:
Substances chimiques
Tacrolimus
WM0HAQ4WNM
Banques de données
ClinicalTrials.gov
['NCT04267991']
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
67-77Références
Jhanji V, Chan TC, Li EY et al (2015) Adenoviral keratoconjunctivitis. Surv Ophthalmol 60(5):435–443
pubmed: 26077630
Kaufman HE (2011) Adenovirus advances: new diagnostic and therapeutic options. Curr Opin Ophthalmol 22(4):290–293
pubmed: 21537185
Altan-Yaycioglu R, Sahinoglu-Keskek N, Canan H et al (2019) Effect of diluted povidone iodine in adenoviral keratoconjunctivitis on the rate of subepithelial corneal infiltrates. Int J Ophthalmol 12(9):1420
pubmed: 31544037
pmcid: 6739576
Okumus S, Coskun E, Tatar MG et al (2012) Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis. BMC Ophthalmol. 12(1):42
pubmed: 22900547
pmcid: 3504581
Otri AM, Fares U, Al-Aqaba MA et al (2012) Corneal densitometry as an indicator of corneal health. Ophthalmology 119(3):501–508
pubmed: 22133793
Muftuoglu IK, Akova YA, Gungor SG (2016) Effect of 0.05% topical cyclosporine for the treatment of symptomatic subepithelial infiltrates due to adenoviral keratoconjunctivitis. Int J Ophthalmol 9(4):634
pubmed: 27162741
pmcid: 4853364
Kuo IC (2019) Adenoviral keratoconjunctivitis: diagnosis, management, and prevention. Current Ophthalmol Rep 7(2):118–127
Jeng BH, Holsclaw DS (2011) Cyclosporine A 1% eye drop for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis. Cornea 30(9):958–961
pubmed: 21673568
Levinger E, Slomovic A, Sansanayudh W et al (2010) Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis. Cornea 29(6):638–640
pubmed: 20458220
Gallego-Pinazo R, Dolz-Marco R, Martínez-Castillo S et al (2013) Update on the principles and novel local and systemic therapies for the treatment of non-infectious uveitis. Inflamm Allergy Drug Targets 12(1):38–45
pubmed: 23441991
Shoughy SS (2017) Topical tacrolimus in anterior segment inflammatory disorders. Eye Vis 4(1):7
Fukushima A, Ohashi Y, Ebihara N et al (2014) Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement. Br J Ophthalmol 98(8):1023–7
pubmed: 24695688
pmcid: 4112440
Magalhaes OA, Marinho DR, Kwitko S (2013) Topical 0.03% tacrolimus preventing rejection in high-risk corneal transplantation: a cohort study. Br J Ophthalmol 97(11):1395–8
pubmed: 24008822
Reddy JC, Rapuano CJ, Felipe AF et al (2014) Quality of vision after excimer laser phototherapeutic keratectomy with intra operative mitomycin-C for Salzmann nodular degeneration. Eye Contact Lens 40(4):213–219
pubmed: 25390548
Lee CS, Lee AY, Akileswaran L et al (2018) Determinants of outcomes of adenoviral keratoconjunctivitis. Ophthalmology 125(9):1344–1353
pubmed: 29602567
pmcid: 6109430
Ye MJ, Liu CY, Liao RF et al (2016) SMILE and wave front-guided LASIK out-compete other refractive surgeries in ameliorating the induction of high-order aberrations in anterior corneal surface. J Ophthalmol 2016:8702162
pubmed: 27818792
pmcid: 5081443
Hu Y, Fang L, Guo X et al (2018) Corneal configurations and high-order aberrations in primary congenital glaucoma. J Glaucoma 27(12):1112–1118
pubmed: 30180018
Elflein HM, Hofherr T, Berisha-Ramadani F et al (2013) measuring corneal clouding in patients suffering from mucopolysaccharidosis with the Pentacam densitometry programme. Br J Ophthalmol 97(7):829–833
pubmed: 23685998
Takacs AI, Mihaltz K, Nagy ZZ (2011) Corneal density with the Pentacam after photorefractive keratectomy. J Refract Surg 27(4):269–277
pubmed: 20672772
Urbaniak D, Seredyka-Burduk M, Błoch W et al (2018) Scheimpflug camera measurement of optical density of the corneal epithelium, stroma, and endothelium in patients with pseudoexfoliation syndrome. Med Sci Monitor Int Med J Experim Clin Res 24:5826
Tekin K, Sekeroglu MA, Kiziltoprak H et al (2017) Corneal densitometry in healthy corneas and its correlation with endothelial morphometry. Cornea 36(11):1336–1342
pubmed: 28872516
Oliveira CM, Ferreira A, Franco S (2012) Wave front analysis and Zernike polynomial decomposition for evaluation of corneal optical quality. J Cataract Refract Surg 38(2):343–356
pubmed: 22176886
Tomlinson A, Bron AJ, Korb DR et al (2011) The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci 52(4):2006–2049
pubmed: 21450918
pmcid: 3072162
Asrar A, Ikram B, Khan H et al (2016) Normal values of corneal optical densitometry using pentacam scheimpflug camera. Adv Ophthalmol Vis Syst 5(1):00142
Dhubhghaill SN, Rozema JJ, Jongenelen S et al (2014) Normative values for corneal densitometry analysis by Scheimpflug optical assessment. Invest Ophthalmol Vis Sci 55(1):162–168
Otri AM, Fares U, Al-Aqaba MA et al (2012) Corneal densitometry as an indicator of corneal health. Ophthalmology 119:501–508
pubmed: 22133793
Nagpal R, Maharana PK, Roop P et al (2020) Phototherapeutic keratectomy. Surv Ophthalmol 65(1):79–108
pubmed: 31306672
Reinstein DZ, Archer TJ, Dickeson ZI et al (2014) Transepithelial phototherapeutic keratectomy protocol for treating irregular astigmatism based on population epithelial thickness measurements by artemis very high-frequency digital ultrasound. J Refract Surg 30(6):380–387
pubmed: 24972404
Labib BA, Minhas BK, Chigbu DI (2020) Management of adenoviral keratoconjunctivitis: challenges and solutions. Clin Ophthalmol 14:837
pubmed: 32256043
pmcid: 7094151
Prado SB, Ayora AC, Fernández CL et al (2017) Topical tacrolimus for corneal subepithelial infiltrates secondary to adenoviral keratoconjunctivitis. Cornea 36(9):1102–1105
Kovalyuk N, Kaiserman I, Mimouni M et al (2017) Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study. Acta Ophthalmol 95(8):e686–92
pubmed: 28342227
Pihos AM (2013) Epidemic keratoconjunctivitis: a review of current concepts in management. J Optometry 6(2):69–74
Tekin K, Kiziltoprak H, Koc M et al (2019) The effect of corneal infiltrates on densitometry and higher-order aberrations. Clin Exp Optometry 102(2):140–146
Aydin Kurna S, Altun A, Oflaz A et al (2015) Evaluation of the impact of persistent subepithelial corneal infiltrates on the visual performance and corneal optical quality after epidemic keratoconjunctivitis. Acta Ophthalmol 93:377–382
pubmed: 25043311
Ghanem RC, da Costa Vargas JF, Ghanem VC (2014) Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis. Cornea 33(11):1210–1213
pubmed: 25188789
Levinger E, Trivizki O, Shachar Y et al (2014) Topical 0.03% tacrolimus for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis. Graefe's Arch Clin Exp Ophthalmol 252(5):811–6
Khurana RN, Li Y, Tang M et al (2007) High-speed optical coherence tomography of corneal opacities. Ophthalmology 114(7):1278–1285
pubmed: 17307254
Yildiz BK, Urvasizoglu S, Yildirim Y et al (2017) Changes in higher-order aberrations after phototherapeutic keratectomy for subepithelial corneal infiltrates after epidemic keratoconjunctivitis. Cornea 36(10):1233–1236
Oliveira RF, Ferreira GA, Ghanem VC et al (2020) Transepithelial surface ablation with mitomycin c for the treatment of chronic central corneal scars following adenoviral keratoconjunctivitis. J Refract Surg 36(1):55–61
pubmed: 31917852
Yamazaki ES, Ferraz CA, Hazarbassanov RM et al (2011) Phototherapeutic keratectomy for the treatment of corneal opacities after epidemic keratoconjunctivitis. Am J Ophthalmol 151(1):35–43
pubmed: 21109229
Mallias IA, Mylova P, Mouzaka A et al (2016) Phototherapeutic keratectomy for the treatment of dense subepithelial infiltrates after epidemic keratoconjunctivitis. Ophthalmol J 1(4):147–150
Medeiros CS, Marino GK, Santhiago MR et al (2018) The corneal basement membranes and stromal fibrosis. Invest Ophthalmol VisSci 59(10):4044–4053
Ghanem RC, Ghanem VC, Ghanem EA et al (2012) Corneal wavefront-guided photorefractive keratectomy with mitomycin-C for hyperopia after radial keratotomy: two-year follow-up. J Cataract Refract Surg 38(4):595–606. https://doi.org/10.1016/j.jcrs.2011.11.032
doi: 10.1016/j.jcrs.2011.11.032
pubmed: 22440434
Alevi D, Barsam A, Kruh J et al (2012) Photorefractive keratectomy with mitomycin-C for the combined treatment of myopia and subepithelial infiltrates after epidemic keratoconjunctivitis. J Cataract Refract Surg 38(6):1028–1033
pubmed: 22624902
Reddy JC, Rapuano CJ, Felipe AF et al (2014) Quality of vision after excimer laser phototherapeutic keratectomy with intraoperative mitomycin-C for Salzmann nodular degeneration. Eye Contact Lens 40:213–219
pubmed: 25390548
Sakata N, Tokunaga T, Miyata K et al (2007) Changes in contrast sensitivity function and ocular higher order aberration by conventional myopic photorefractive keratectomy. Jpn J Ophthalmol 51(5):347–352
pubmed: 17926111